top of page

Publications

Review Article

Use of tumour-responsive T cells as cancer treatment

T Cell Function & Therapy

2009

Authors:

Disis M.L., Bernhard H., Jaffee E.M.

Journal:

Lancet

Volume:

373(9664)

Page:

673-83

Original Article

Toward a stem cell gene therapy for breast cancer

General Immune Research

2009

Authors:

Li Z, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem HP, Disis ML, Lieber A.

Journal:

Blood

Volume:

113(22)

Page:

5423-5433

Review Article

Immunomodulation of breast cancer via tumor antigen specific Th1

Cancer Vaccines

2009

Authors:

Disis M.L., Park K.H.

Journal:

Cancer Research Treatment

Volume:

41(3)

Page:

117-21

Review Article

Cellular Immune Strategies For Cancer Therapy

T Cell Function & Therapy

2009

Authors:

Disis ML, Jaffe EM and Bernhard H

Journal:

Lancet

Volume:

Page:

Pubmed:

Original Article

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer

Cancer Vaccines

2009

Authors:

Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA, Dela Rosa C, Tietje K, Link J, Waisman J, Salazar LG.

Journal:

Journal of Clinical Oncology

Volume:

27(28)

Page:

4685-92

Original Article

In situ adenovirus vaccination engages T effector cells against cancer

Cancer Vaccines

2009

Authors:

Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellstrom KE, Disis ML, Roffler S, Lieber A.

Journal:

Vaccine

Volume:

27(31)

Page:

4225-39

Original Article

Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity

Cancer Vaccines

2009

Authors:

Coveler AL, Goodell V, Webster DJ, Salazar LG, Fintak PA, Childs JS, Higgins DM and Disis ML

Journal:

Breast Cancer Research and Treatment

Volume:

113(1)

Page:

95-100

Original Article

Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation

Clinical Trials

2009

Authors:

Emens LA, Asquith JM, Leatherman JM, Kobrin BJ, Petrik S, Laiko M, Levi J, Daphtary MM, Biedrzycki B, Wolff AC, Stearns V, Disis ML, Ye X, Piantadosi S, Fetting JH, Davidson NE, Jaffee EM.

Journal:

Journal of Clinical Oncology

Volume:

27(35)

Page:

5911-8

Original Article

Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer

Measuring Human Immunity

2009

Authors:

Dang Y and Disis ML

Journal:

Annals of the New York Academy of Sciences

Volume:

1174

Page:

81-7

Original Article

Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor

Cancer Diagnostics

2009

Authors:

Ladd J, Lu H, Taylor AD, Goodell V, Disis ML, Jiang S

Journal:

Colloids and Surfaces B: Biointerfaces

Volume:

70(1)

Page:

1-6

bottom of page